News
What if you could experience full health until the very end of your life? UA researchers, led by Dr. Janko Nikolich-Zugich, think long-lasting immunity from disease might be possible — if the thymus and the T-cells it produces to fight infection can be brought back to work efficiently.
Congratulations to Dr. Noel Warfel who was awarded a Lung Cancer Discovery Award, a one year $100,000 grant from the American Lung Association to fund his project “Targeting PIM kinases to Oppose Nrf2-driven Lung Cancers”
What does it mean to be a scientist? Far more than doing research in a lab, says Michael Johnson, whose unconventional passage into the field began with a bowling championship and a music degree.
In a recent study led by UA Assistant Professor Casey Romanoski, PhD, the research team used genome-wide epigenetics to identify major drivers of human artery endothelial cell responses to inflammatory environments. They utilized endothelial genome sequences called enhancers to pinpoint DNA variation in humans that may underpin differential susceptibility to coronary artery disease. Their findings, published June 6th in eLIFE (https://elifesciences.org/articles/22536), improve our understanding of vascular biology and moves us one step closer to understanding the molecular mechanisms of disease.
Congratulations to Dr. Keith Maggert who has received the prestigious NIH Director’s Transformative Research Award, a five-year $1.7 million grant from the National Institutes of Health to fund his project “Induced transgenerational inheritance without epigenetics”.
Weekly CMM/IMB joint student seminar schedule
On Saturday, November 19th our Department Head, Dr. Janko Nikolich-Žugich, will be named the Chair of the Biological Section of the Gerontological Society of America (GSA)!
Keith Maggert, PhD, with the University of Arizona Cancer Center and associate professor of cellular and molecular medicine, has been awarded a $1.7 million NIH grant and has been recognized for his high-risk/high-reward research that has the potential to change the way we think about epigenetics in disease.